Indeed, approximately 30% of CDA II patients exhibit a tendency to iron overload (ferritin > 300 ng/mL), while 17% of them show marked hemosiderosis (ferritin > 600 ng/mL) even regardless of the regimen of transfusion dependence [15]. The gene discussed is CDA; the disease is hemosiderosis.